Colin Cahill joined Venrock as a vice president in 2012 and focuses on healthcare investments. Prior to joining Venrock, Colin was a co-founder and Chief Development Officer at Simpirica Spine, a Bay Area medical device company focused on the development and commercialization of devices for spinal stabilization. He served as the company’s CEO from 2006-2009. Before Simpirica, Colin spent summers in the life sciences group at InterWest Partners and in endosurgery clinical affairs at Boston Scientific. He has also spent several years in business development and operations for biotech startups and has served as a strategy consultant at the Boston Consulting Group for pharmaceutical companies in the U.S. and Europe.
Colin received an MBA from the Stanford Graduate School of Business, where he was an Arjay Miller Scholar. Prior to business school, he completed an M.S. in Biological Sciences at Stanford, during which he performed research related to cardiac cell therapy. Colin received his undergraduate degrees in Biological Sciences and Economics from Stanford University.